메뉴 건너뛰기




Volumn 6, Issue 2, 1997, Pages 103-108

Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer

Author keywords

QLQ C30; quality of life; revisions

Indexed keywords

ADULT; AGED; ARTICLE; CANCER THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; CANADA; CONTENT VALIDITY; CRONBACH ALPHA COEFFICIENT; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE CORE 30; HUMAN TISSUE; INTERNAL CONSISTENCY; NETHERLANDS;

EID: 8244243951     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (173)

References (16)
  • 1
    • 0001031756 scopus 로고
    • The EORTC core quality of life questionnaire: Interim results of an international field study
    • Osoba D, ed. Boca Raton, FL (USA): CRC Press
    • Aaronson NK, Ahmedzai S, Bullinger M, et al. The EORTC core quality of life questionnaire: interim results of an international field study. In: Osoba D, ed. Effect of Cancer on Quality of Life. Boca Raton, FL (USA): CRC Press, 1991: 185-203.
    • (1991) Effect of Cancer on Quality of Life , pp. 185-203
    • Aaronson, N.K.1    Ahmedzai, S.2    Bullinger, M.3
  • 2
    • 0027417437 scopus 로고
    • The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international trials in oncology
    • Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 365-376
    • Aaronson, N.K.1    Ahmedzai, S.2    Bergman, B.3
  • 3
    • 0028063346 scopus 로고
    • Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer
    • Osoba D, Zee B, Pater J, et al. Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 1994; 3: 353-364.
    • (1994) Qual Life Res , vol.3 , pp. 353-364
    • Osoba, D.1    Zee, B.2    Pater, J.3
  • 4
    • 0026778086 scopus 로고
    • Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients
    • Bjordal K, Kaasa S. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol 1992; 31: 311-321.
    • (1992) Acta Oncol , vol.31 , pp. 311-321
    • Bjordal, K.1    Kaasa, S.2
  • 5
    • 0027286142 scopus 로고
    • Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogenous diagnoses
    • Ringdal GI, Ringdal K. Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogenous diagnoses. Qual Life Res 1993; 2: 129-140.
    • (1993) Qual Life Res , vol.2 , pp. 129-140
    • Ringdal, G.I.1    Ringdal, K.2
  • 6
    • 0027131378 scopus 로고
    • A validation study of the domains of the core EORTC Quality of Life questionnaire
    • Niezgoda HE, Pater JL. A validation study of the domains of the core EORTC Quality of Life questionnaire. Qual Life Res 1993; 2: 319-325.
    • (1993) Qual Life Res , vol.2 , pp. 319-325
    • Niezgoda, H.E.1    Pater, J.L.2
  • 7
    • 0029033528 scopus 로고
    • Test/retest study of the European Organization for Research and Treatment of Cancer core Quality-of-Life Questionnaire
    • Hjermstad MJ, Fossa SD, Bjordal K, et al. Test/retest study of the European Organization for Research and Treatment of Cancer core Quality-of-Life Questionnaire. J Clin Oncol 1995; 13: 1249-1254.
    • (1995) J Clin Oncol , vol.13 , pp. 1249-1254
    • Hjermstad, M.J.1    Fossa, S.D.2    Bjordal, K.3
  • 8
    • 0028598312 scopus 로고
    • The Karnofsky performance status scale re-examined: A cross-validation with the EORTC-C30
    • Schaafsma J, Osoba D. The Karnofsky performance status scale re-examined: a cross-validation with the EORTC-C30. Qual Life Res 1994; 3: 413-424.
    • (1994) Qual Life Res , vol.3 , pp. 413-424
    • Schaafsma, J.1    Osoba, D.2
  • 9
    • 0029185935 scopus 로고
    • The EORTC Core Quality of Life Questionnaire (QLQ-C30): Validity and reliability when analyzed with patients treated with palliative radiotherapy
    • Kaasa S, Bjordal K, Aaronson N, et al. The EORTC Core Quality of Life Questionnaire (QLQ-C30): Validity and reliability when analyzed with patients treated with palliative radiotherapy. Eur J Cancer 1995; 31A: 2260-2263.
    • (1995) Eur J Cancer , vol.31 A , pp. 2260-2263
    • Kaasa, S.1    Bjordal, K.2    Aaronson, N.3
  • 11
    • 33845945922 scopus 로고
    • Coefficient alpha and the internal structure of tests
    • Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
    • (1951) Psychometrika , vol.16 , pp. 297-334
    • Cronbach, L.J.1
  • 12
    • 0342783539 scopus 로고
    • Dolasetron vs. ondansetron with or without dexamethasone in the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    • Lofters W, Zee B. Dolasetron vs. ondansetron with or without dexamethasone in the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy [abstract]. Support Care Cancer 1995; 3: 338.
    • (1995) Support Care Cancer , vol.3 , pp. 338
    • Lofters, W.1    Zee, B.2
  • 13
    • 0344344875 scopus 로고
    • Effective antiemetic therapy improves quality of life (QOL) after moderately emetogenic chemotherapy (MEC)
    • Osoba D, Pater JL, Zee B, et al. Effective antiemetic therapy improves quality of life (QOL) after moderately emetogenic chemotherapy (MEC) [abstract]. Qual Life Res 1995; 4: 467-468.
    • (1995) Qual Life Res , vol.4 , pp. 467-468
    • Osoba, D.1    Pater, J.L.2    Zee, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.